Ampreloxetine clinical development program to be featured in four presentations at the upcoming International Symposium on The Autonomic Nervous System ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., /PRNewswire/ -- CND Life Sciences (CND) ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

The fireside chat will be held from 11:00-11:25am Eastern Time and a live webcast of the presentation may be accessed by visiting the Events page of the Company’s website at ...

Modern sedentary lifestyles silently harm the body, leading to weight gain, weakened muscles and bones, and increased risk of ...

CuraSen Therapeutics has commenced its Phase IIa proof-of-concept trial of CuraAX (CST-3056) with dosing of the first patient ...

7 This causes congestion in the body’s tissues ... limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s end-to-end gene therapy platform includes ...

A mother and her daughter with a rare disease in Guangzhou, South China's Guangdong Province, on January 31, 2024 Photo: VCG.